c-Cbl and Cbl-b regulate T cell responsiveness by promoting ligand-induced TCR down-modulation

被引:315
|
作者
Naramura, M
Jang, IK
Kole, H
Huang, F
Haines, D
Gu, H [1 ]
机构
[1] NIAID, Immunol Lab, NIH, Rockville, MD 20852 USA
[2] NCI, Pathol Histotechnol Lab, Frederick Canc Res & Dev Ctr, Frederick, MD 21702 USA
关键词
D O I
10.1038/ni855
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
How Cbl family proteins regulate T cell responses is unclear. We found that c-Cbl Cbl-b double knockout (dKO) T cells became hyperresponsive upon anti-CD3 stimulation, even though the major T cell antigen receptor (TCR) signaling pathways were not enhanced. The dKO T cells did not down-modulate surface TCR after ligand engagement, which resulted in sustained TCR signaling. However, these cells showed normal ligand-independent TCR internalization, and trafficking of internalized TCR to the lysosome compartment after ligand engagement was reduced. These findings show that Cbl family proteins negatively regulate T cell activation by promoting clearance of engaged TCR from the cell surface, a process that is apparently essential for the termination of TCR signals.
引用
收藏
页码:1192 / 1199
页数:8
相关论文
共 42 条
  • [41] Chlorogenic Acid Inhibits Osteodast Differentiation and Bone Resorption by Down-Regulation of Receptor Activator of Nuclear Factor Kappa-B Ligand-Induced Nuclear Factor of Activated T Cells c1 Expression
    Kwak, Sung Chul
    Lee, Cheol
    Kim, Ju-Young
    Oh, Hyun Mee
    So, Hong-Seob
    Lee, Myeung Su
    Rho, Mun Chual
    Oh, Jaemin
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2013, 36 (11) : 1779 - 1786
  • [42] Inhibition of Tumor Progression Locus 2 Protein Kinase Suppresses Receptor Activator of Nuclear Factor-κB Ligand-Induced Osteoclastogenesis through Down-Regulation of the c-Fos and Nuclear Factor of Activated T Cells c1 Genes
    Hirata, Kazuya
    Taki, Hirofumi
    Shinoda, Kouichiro
    Hounoki, Hiroyuki
    Miyahara, Tatsuro
    Tobe, Kazuyuki
    Ogawa, Hirofumi
    Mori, Hisashi
    Sugiyama, Eiji
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2010, 33 (01) : 133 - 137